74 related articles for article (PubMed ID: 20810246)
41. Aberrant expression of CD6 on B-cell subsets from patients with Sjögren's syndrome.
Alonso R; Buors C; Le Dantec C; Hillion S; Pers JO; Saraux A; Montero E; Marianowski R; Loisel S; Devauchelle V; Youinou P; Renaudineau Y
J Autoimmun; 2010 Dec; 35(4):336-41. PubMed ID: 20810246
[TBL] [Abstract][Full Text] [Related]
42. What do we know about memory B cells in primary Sjögren's syndrome?
Hansen A; Daridon C; Dörner T
Autoimmun Rev; 2010 Jul; 9(9):600-3. PubMed ID: 20452465
[TBL] [Abstract][Full Text] [Related]
43. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue.
Hansen A; Lipsky PE; Dörner T
Arthritis Res Ther; 2007; 9(4):218. PubMed ID: 17697366
[TBL] [Abstract][Full Text] [Related]
44. In Sjögren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation.
Varin MM; Guerrier T; Devauchelle-Pensec V; Jamin C; Youinou P; Pers JO
Autoimmun Rev; 2012 Feb; 11(4):252-8. PubMed ID: 22001522
[TBL] [Abstract][Full Text] [Related]
45. B cell-targeted therapies in Sjögren's syndrome.
Tobón GJ; Pers JO; Youinou P; Saraux A
Autoimmun Rev; 2010 Feb; 9(4):224-8. PubMed ID: 19671451
[TBL] [Abstract][Full Text] [Related]
46. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO
Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
[TBL] [Abstract][Full Text] [Related]
47. Are the B cells cast with the leading part in the Sjogren's syndrome scenario?
Pers JO; Youinou P
Oral Dis; 2014 Sep; 20(6):529-37. PubMed ID: 23837848
[TBL] [Abstract][Full Text] [Related]
48. The role of intrinsic epithelial activation in the pathogenesis of Sjögren's syndrome.
Manoussakis MN; Kapsogeorgou EK
J Autoimmun; 2010 Nov; 35(3):219-24. PubMed ID: 20685080
[TBL] [Abstract][Full Text] [Related]
49. Lymphoproliferative disorders in Sjögren's syndrome.
Masaki Y; Sugai S
Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
[TBL] [Abstract][Full Text] [Related]
50. Immunologic and viral factors in Sjögren's syndrome.
Talal N
Clin Exp Rheumatol; 1990; 8 Suppl 5():23-6. PubMed ID: 1700940
[TBL] [Abstract][Full Text] [Related]
51. Sjögren's syndrome: an oligo-monoclonal B cell process.
Tzioufas AG; Katsikis PD; Youinou PY; Moutsopoulos HM
Clin Exp Rheumatol; 1990; 8 Suppl 5():17-21. PubMed ID: 1700939
[TBL] [Abstract][Full Text] [Related]
52. Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies.
Vossenkämper A; Lutalo PM; Spencer J
Clin Exp Immunol; 2012 Jan; 167(1):7-14. PubMed ID: 22132879
[TBL] [Abstract][Full Text] [Related]
53. CD5+ B cells in nonorgan-specific autoimmune diseases: a fresh look.
Youinou P; Lydyard PM
Lupus; 2001; 10(8):523-5. PubMed ID: 11530992
[No Abstract] [Full Text] [Related]
54. Disturbance of cytokine networks in Sjögren's syndrome.
Youinou P; Pers JO
Arthritis Res Ther; 2011 Jul; 13(4):227. PubMed ID: 21745420
[TBL] [Abstract][Full Text] [Related]
55. B cell development pathways.
Hardy RR; Hayakawa K
Annu Rev Immunol; 2001; 19():595-621. PubMed ID: 11244048
[TBL] [Abstract][Full Text] [Related]
56. CD6 as a therapeutic target in autoimmune diseases: successes and challenges.
Pinto M; Carmo AM
BioDrugs; 2013 Jun; 27(3):191-202. PubMed ID: 23568178
[TBL] [Abstract][Full Text] [Related]
57. Contribution of Evolutionary Selected Immune Gene Polymorphism to Immune-Related Disorders: The Case of Lymphocyte Scavenger Receptors
Casadó-Llombart S; Velasco-de Andrés M; Català C; Leyton-Pereira A; Lozano F; Bosch E
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070159
[TBL] [Abstract][Full Text] [Related]
58. Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.
Velasco-de Andrés M; Casadó-Llombart S; Català C; Leyton-Pereira A; Lozano F; Aranda F
Cells; 2020 Dec; 9(12):. PubMed ID: 33287301
[TBL] [Abstract][Full Text] [Related]
59. The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations.
Kofler DM; Farkas A; von Bergwelt-Baildon M; Hafler DA
Curr Drug Targets; 2016; 17(6):651-65. PubMed ID: 26844569
[TBL] [Abstract][Full Text] [Related]
60. [CD5 and CD6 molecules--similarities and differences].
Rupniewska ZM; Dmoszyńska M; Roliński J
Pol Arch Med Wewn; 1999 Mar; 101(3):245-50. PubMed ID: 10697403
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
